Tag:
HIV vaccine
Latest Headlines
Latest Headlines
Profectus immunizes first patient in Ph1 HIV vax trial
Baltimore-based Profectus Biosciences has inoculated its first patient in a Phase I trial of its multi-antigen DNA HIV vaccine. The study will monitor 60 HIV patients who are on stable
Dana-Farber finds new AIDS vax target
The Dana-Farber Cancer Institute is making progress toward an AIDS vaccine thanks to a relatively stable portion of the virus' protein envelope. By targeting the protein strand, called the V3 loop,
HIV vaccine researchers ponder new strategies, drop in funding
Emboldened by a glimpse of the potential of a new HIV vaccine, more than 1,000 researchers from around the world are gathering in Atlanta this week to share their thoughts on the best strategies for
Encouraging steps in AIDS fight prompt hope for 'renaissance'
With recent advances toward creating a viable HIV vaccine, experts are hopeful for the beginning of the "renaissance" of HIV and AIDS treatment--especially during the buzz of the Vienna AIDS
Two new antibodies may lead to HIV/AIDS vaccine
Federal researchers have discovered two antibodies that may bring about the renaissance of HIV and AIDS treatment. The antibodies, VRC01 and VRC02, can kill up to 90 percent of HIV strains, compared
New study highlights an unexplored HIV vax path
Using a computer model, researchers have been able to identify the unique genetic profile of people most likely to carry highly reactive sets of T cells, which makes them part an elite group of
HIV vax trial recruiters get edgy with social media strategies
One of the hottest trends in clinical trial development these days is the use of social media to recruit suitable subjects, and that hasn't gone unnoticed in HIV vaccine research circles. The HIV
Finalists ponder fate of $88M HIV facility
The four finalists for an $88 million project to build a new facility in Canada to produce an HIV vaccine say the government has left them in the dark about the reasons why no one has been selected
Thai HIV vax trial controversy continues to brew
The post mortems on the Thai HIV vaccine trial continue to pour in following the revelation in the New York Times that AIDS researchers briefed on the results found out that a separate--and initially
AIDS vax a surprising success in big trial
AIDS vaccine investigators would have taken just about any positive indication in a major human trial as a hopeful sign. And today many were clearly impressed to see that a huge study of a combo HIV
